![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Quarterly Drug Pipeline: January 2025 - Prime Therapeutics
The pipeline drug list is an aerial outline of drugs with anticipated FDA approval through 2026. It is not intended to be a comprehensive inventory of all drugs in the pipeline; emphasis is placed on drugs in high-impact categories. Investigational drugs with a recent Complete Response Letter (CRL) are also reported.
January 2025 Recap: Drug Pipeline Updates - MPR
1 day ago · Drug: Pharmacologic Class: Proposed Indication: Status Cardiovascular Disease: Bumetanide nasal spray (RSQ-777; Corstasis Therapeutics) Loop diuretic: Treatment of edema associated with congestive ...
New Drug Development Pipeline: Pfizer's Medicine, Vaccine …
A U.S. drug application will receive a priority review designation if it is for a drug that treats a serious condition and, if approved, would provide a significant improvement in safety or effectiveness.
Drug pipeline - Wikipedia
A drug pipeline is the set of drug candidates that an individual pharmaceutical company [1] or the entire pharmaceutical industry collectively has under discovery or development at any given point in time. [2]
Pipeline - Merck.com
Nov 1, 2024 · The chart reflects the company research pipeline as of November 1, 2024. Candidates shown in Phase 3 include specific products. Candidates shown in Phase 2 include the most advanced compound with a specific mechanism in a given therapeutic area.
Drug Product Pipeline Resources | AMCP.org
AMCP and Apperture are proud to present the AMCP Drug Product Pipeline, the latest innovation in providing access and insight into the formulary decision-making process.
Regeneron | Investigational Pipeline and Medicines in Development
Explore Regeneron’s clinical pipeline. Our pipeline is powered by end-to-end research and development capabilities, and our portfolio of investigational medicines reflects the true collaborative spirit of Regeneron. The Research team discovers promising new drug candidates.
Human Pharma Clinical Pipeline | Boehringer Ingelheim
Of pipeline anchored in external collaborations (across research, pre-clinical and clinical portfolios)
Drug pipeline 1Q23 — Everything everywhere all over the place
May 16, 2023 · There were three approvals for treatments for rare or ultra-rare diseases in the first quarter of 2023: Chiesi Farmaceutici’s α-mannosidase replacement enzyme Lamzede and small-molecule treatments...
Quarterly Drug Pipeline: October 2024 - Prime Therapeutics
Welcome to the Prime Quarterly Drug Pipeline! Dive into clinical insights and competitive intelligence on anticipated drugs in development, so you are well-sourced on the drug pipeline. The drug pipeline is complex and fluid.